ChinaSavvy lands $1.3 million engineering contract to supply components for high-tech storage systems
The initial US$1.3 million order is to supply components for ultra low temperature robotic storage systems in the US to major pharmaceutical companies.
ChinaSavvy is in receipt of a USD 1.3 million order to supply components for high-tech robotic storage systems by Hamilton Storage, a global company with headquarters in Massachusetts, US.
ChinaSavvy is a British owned and managed engineering and manufacturing company based in China. The company, founded in 2003, was established with the primary aim of delivering world-class engineering and manufacturing services to blue-chip companies in the US, UK, Australia and many other countries around the globe, while taking advantage of low Chinese manufacturing costs.
In the bid to achieve world-class engineering in China, Chinasavvy, an ISO 9001-2008 company, recruited highly qualified engineers and tech veterans and coupled them with state-of-the-art technology in the engineering and manufacturing industry. The company has earned a global reputation in the delivery of high quality, world-class engineering and manufacturing services at affordable prices. ChinaSavvy’s customer base is extremely loyal with companies continuing to rely on Chinasavvy for engineering and manufacturing after 10 to 12 years. And Hamilton has already indicated a long-term commitment to Chinasavvy for further components and systems.
The initial US$1.3 million order is to supply components for ultra low temperature robotic storage systems in the US to major pharmaceutical companies. Hamilton Storage, part of the Hamilton group, has operations world-wide and are leaders in this field.
Christopher Devereux, the Managing Director of ChinaSavvy said: “We are committed to ensuring that we deliver exceptional world-class engineering and manufacturing services to Hamilton Storage, to cement the business partnership and prove to them that they have taken the right business decision. Once again we have shown that ‘China pricing’ can go hand in hand with exceptional quality and on-time deliveries. For this order we are combining various manufacturing skills including: aluminium extrusion and punching; laser cutting, die-casting; injection moulding; fabrication and assembly.”
Dave Recchia, Head of Purchasing at Hamilton Storage said:, “Hamilton Storage conducted an extensive search for a new manufacturing partner last summer. During this search our purchasing team discovered ChinaSavvy. It became evident very quickly during the quoting process that ChinaSavvy was unique among other vendors in Asia. We were very impressed with the turnaround time on quotes, the ease of communication in English, and also the highly competitive pricing.”
John Genereux, Director of R&D at Hamilton Storage, added: “As initial work progresses we see ChinaSavvy’s commitment to our project and their deep focus on sound engineering and overall product quality. Hamilton Storage looks forward to a long productive partnership with ChinaSavvy and would recommend them to other companies looking for a highly competent partner in Asia.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance